Feb. 19, 2024, 5:42 a.m. | Peter Eckmann, Dongxia Wu, Germano Heinzelmann, Michael K Gilson, Rose Yu

cs.LG updates on arXiv.org arxiv.org

arXiv:2402.10387v1 Announce Type: cross
Abstract: Current generative models for drug discovery primarily use molecular docking to evaluate the quality of generated compounds. However, such models are often not useful in practice because even compounds with high docking scores do not consistently show experimental activity. More accurate methods for activity prediction exist, such as molecular dynamics based binding free energy calculations, but they are too computationally expensive to use in a generative model. We propose a multi-fidelity approach, Multi-Fidelity Bind (MFBind), …

abstract arxiv cs.lg current discovery drug discovery experimental fidelity generated generative generative modeling generative models modeling molecular docking practical practice q-bio.bm quality show type

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Senior ML Engineer

@ Carousell Group | Ho Chi Minh City, Vietnam

Data and Insight Analyst

@ Cotiviti | Remote, United States